Research workbench
Crystal structure of an engineered cro monomer bound nonspecifically to DNA
Analyse Crystal structure of an engineered cro monomer bound nonspecifically to DNA in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 3ORC
- Type
- protein + DNA
- Length
- 81 residues
- Chains
- 3
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- DNA (5'-D(*TP*AP*TP*CP*GP*AP*TP*A)-3'); Protein (cro repressor)
- UniProt
- P03040
- Pockets
- 1 · best druggability 0.41
Structure
x-ray diffraction · 2 distinct chains · 40% helix, 28% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| R, S | DNA (5'-D(*TP*AP*TP*CP*GP*AP*TP*A)-3') | dna | 8 | — | — |
| A | Protein (cro repressor) | protein | 65 | 40% helix, 28% strand | P03040 |
Pockets
1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 81 | 0.41 | 0.79 | 14 | empty |
Interfaces
3 interfaces between chains.
- R–S · 371 Ų buried · 42 hydrogen bonds · nucleic-nucleic
- S–A · 364 Ų buried · 8 hydrogen bonds · protein-nucleic
- R–A · 166 Ų buried · 2 hydrogen bonds · protein-nucleic
Compared structures
- 3ORC · Crystal structure of an engineered cro monomer bound nonspecifically to DNA · the same entry in another collection · chain R against R, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P03040
- Elsewhere: RCSB PDB 3ORC · PDBe 3ORC · UniProt P03040
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.